Quantitative and Repetitive TMS in ALS - Recruiting for Stage 2

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

April 15, 2026

Study Completion Date

April 15, 2027

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DEVICE

Repetitive Transcranial Magnetic Stimulation

"Stage 2 \[CURRENTLY ENROLLING\]:~Accelerated rTMS using continuous theta burst stimulation (cTBS) inhibitory paradigms over bilateral M1 including hand, leg, and bulbar regions outputted at 90% of resting motor threshold, using bursts of 3 pulses at 50 Hz. Bursts are repeated at 5 Hz for a total of 600, 1200, 1800, or 3600 pulses over 40 seconds, 1 minute 20 seconds, 2 minutes, or 4 minutes. ALS patients will receive rTMS bilaterally for up to 8 treatment sessions per day, delivered one per hour, over 5 days, followed by single-day maintenance treatments at a frequency of every 2 weeks for 12 weeks, then every 4 weeks for 12 weeks."

Trial Locations (1)

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER